The Baricitinib Tablet, cataloged under National Stock Number 6505-01-688-4626, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Eli Lilly and Company. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-688-4626 |
| Primary Part Number | NDC00002-4182-30 |
| Item Name | Baricitinib Tablet |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Eli Lilly and Company |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00002-4182-30 PRIMARY | Eli Lilly and Company (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM206284 | 5/1 Secondary reference Defense Medical Standardization Board |
| OLUMIANT | 5/1 Secondary reference Eli Lilly and Company |
| 1575362 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-688-4626 is a Baricitinib Tablet, manufactured by Eli Lilly and Company, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-688-4626 has 1 manufacturer part number on file: NDC00002-4182-30 (Eli Lilly and Company).
Key specifications for NDC00002-4182-30: Special Features: INDICATED FOR REDUCING THE SIGNS AND SYMPTOMS OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN ADULT PATIENTS WHO HAVE RESPONDED INADEQUATELY TO ONE OR MORE DISEASE MODIFYING ANTI-RHEUMATIC DRUGS; BARICITINIB INHIBITS JANUS KINASES (JAK) AND MODULATES SIGNAL PATHWAYS; 2MG TABLETS; BOTTLE OF 30; STORE AT 20 TO 25 C (68 TO 77 F); EXCURSIONS PERMITTED TO 15 TO 30 C (59 TO 86 F) (SEE USP CONTROLLED ROOM TEMPERATURE); KEEP OUT OF REACH OF CHILDREN.; Part Name Assigned by Controlling Agency: BARICITINIB TABLETS, ARTHRITIS TREATMENT, 2MG, 30S,. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.